Zhang, Bingjie
Srivastava, Avi http://orcid.org/0000-0001-9798-2079
Mimitou, Eleni http://orcid.org/0000-0001-9737-6394
Stuart, Tim http://orcid.org/0000-0002-3044-0897
Raimondi, Ivan
Hao, Yuhan
Smibert, Peter http://orcid.org/0000-0003-0772-1647
Satija, Rahul http://orcid.org/0000-0001-9448-8833
Funding for this research was provided by:
Jane Coffin Childs Memorial Fund for Medical Research
U.S. Department of Health & Human Services | NIH | National Cancer Institute (K99CA267677-01, K99HG011489-01, DP2HG009623-01)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (RM1HG011014-02)
U.S. Department of Health & Human Services | NIH | NIH Office of the Director (1OT2OD026673-01)
Article History
Received: 14 September 2021
Accepted: 7 February 2022
First Online: 24 March 2022
Competing interests
: In the past three years, R.S. has worked as a consultant for Bristol Myers Squibb, Regeneron and Kallyope and served as scientific advisory board member for ImmunAI, Resolve Biosciences, NanoString and the NYC Pandemic Response Lab. P.S. is co-inventor of a patent related to this work. The other authors declare no competing interests.